Benmoxin (trade names Neuralex Nerusil) also known as mebamoxine is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class. It was synthesized in 1967 and was subsequently used as an antidepressant in Europe but is now no longer marketed.
This page contains content from the copyrighted Wikipedia article "Benmoxin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.